) stock plunged 19% on Wednesday after the company said it would delay the filing of its annual report for its fiscal year that ended June 30."SMCI is unable to file its Annual Report within the prescribed time period without unreasonable effort or expense," the company. "Additional time is needed for SMCI’s management to complete its assessment of the design and operating effectiveness of its internal controls over financial reporting as of June 30, 2024.
CAMBRIDGE, Mass., August 28, 2024--Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences: NEW YORK, Aug. 28, 2024 -- SIM Acquisition Corp. I announced today that, commencing August 30, 2024, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on thMOUNTAIN VIEW, Calif.
Malaysia Malaysia Latest News, Malaysia Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Source: YahooFinanceCA - 🏆 47. / 63 Read more »